IRIS
PIRTOLI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.571
EU - Europa 7.782
AS - Asia 3.854
SA - Sud America 646
AF - Africa 71
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 9
Totale 20.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.444
GB - Regno Unito 2.021
RU - Federazione Russa 1.597
CN - Cina 1.486
SG - Singapore 1.227
IE - Irlanda 1.023
IT - Italia 647
UA - Ucraina 638
BR - Brasile 568
SE - Svezia 560
DE - Germania 479
HK - Hong Kong 324
FR - Francia 313
FI - Finlandia 218
VN - Vietnam 209
KR - Corea 206
IN - India 100
ES - Italia 91
TR - Turchia 69
CA - Canada 68
JP - Giappone 39
MX - Messico 37
BD - Bangladesh 34
NL - Olanda 32
PL - Polonia 30
BE - Belgio 28
AR - Argentina 26
IQ - Iraq 26
ZA - Sudafrica 23
ID - Indonesia 21
IR - Iran 20
AT - Austria 19
AU - Australia 18
LT - Lituania 16
EC - Ecuador 14
IM - Isola di Man 14
SA - Arabia Saudita 14
UZ - Uzbekistan 13
DK - Danimarca 11
MA - Marocco 11
PK - Pakistan 11
CZ - Repubblica Ceca 8
TN - Tunisia 8
VE - Venezuela 8
CI - Costa d'Avorio 7
EU - Europa 7
KE - Kenya 7
MY - Malesia 7
PH - Filippine 6
PY - Paraguay 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
CL - Cile 5
CO - Colombia 5
JM - Giamaica 5
NP - Nepal 5
AL - Albania 4
AZ - Azerbaigian 4
BG - Bulgaria 4
GR - Grecia 4
JO - Giordania 4
NO - Norvegia 4
OM - Oman 4
PA - Panama 4
PE - Perù 4
RS - Serbia 4
BB - Barbados 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
IL - Israele 3
RO - Romania 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 20.944
Salva come PNG Salva come JPEG
Città #
Southend 1.774
Dublin 1.004
Dallas 948
Fairfield 841
Singapore 764
Ashburn 645
Chandler 617
Jacksonville 486
Santa Clara 460
Moscow 441
Woodbridge 403
Beijing 393
Wilmington 372
Hong Kong 321
Seattle 308
Houston 305
Ann Arbor 300
Cambridge 249
Hefei 223
Seoul 203
Princeton 197
Siena 194
Nanjing 173
New York 160
Menlo Park 144
Fremont 108
Los Angeles 98
Helsinki 94
San Mateo 94
Munich 86
Dearborn 76
Málaga 70
Boardman 68
The Dalles 68
Ho Chi Minh City 63
Buffalo 53
Shanghai 52
Shenyang 51
Izmir 47
Nanchang 47
Florence 46
Milan 45
San Diego 44
São Paulo 43
Hanoi 41
London 38
Dong Ket 37
Rome 37
Tianjin 36
Kunming 30
Council Bluffs 29
Brussels 28
Columbus 28
Lancaster 27
Turku 25
Warsaw 25
Hebei 24
Montreal 24
Tokyo 24
Changsha 23
Jinan 23
Redondo Beach 23
Rio de Janeiro 22
Toronto 22
Zhengzhou 22
Bengaluru 20
San Francisco 20
Falkenstein 19
Phoenix 19
Denver 18
Guangzhou 18
Jiaxing 18
Venezia 17
Brooklyn 16
Hangzhou 16
Nuremberg 16
Redwood City 16
Stockholm 16
Atlanta 15
Johannesburg 15
Orem 15
Douglas 14
Belo Horizonte 13
Chicago 13
Düsseldorf 13
Falls Church 13
Ningbo 13
Bari 12
Boston 11
Chennai 11
Norwalk 11
Bologna 10
Frankfurt am Main 10
Lappeenranta 10
Piscataway 10
Poplar 10
Tashkent 10
Vienna 10
Brasília 9
Mexico City 9
Totale 14.252
Salva come PNG Salva come JPEG
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 364
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 331
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 314
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients 312
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 299
Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma 298
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 298
microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to Temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells 296
Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence 285
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 283
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 280
Diffusion-weighted magnetic resonance diagnosis of local recurrences of prostate cancer after radical prostatectomy: preliminary evaluation on twenty-seven cases 263
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 254
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 250
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 250
Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells 249
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 242
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 242
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 236
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 235
Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki-67 and expression of cyclins D1 and A in cutaneous melanoma 229
Beta-catenin and Gli1 are prognostic markers in glioblastoma 228
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 223
AUTOCOUNTER, an ImageJ JavaScript to analyze LC3B-GFP expression dynamics in autophagy-induced astrocytoma cells 214
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and Temozolomide combined treatments 210
Lymphoepithelioma-like carcinoma of the endometrium 206
Diffusion-weighted MR volumetry for assessing the response of rectal cancer to combined radiation therapy with chemotherapy 204
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). 203
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach 203
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 202
Carcinoma with eccrine differentiation arising in a seborrhoeic keratosis. 200
Emerging roles of microRNA in modulating cell-death processes in malignant glioma 199
Beta-Catenin and Gli-1 as prognostic markers in Glioblastoma Multiforme. 198
Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells 195
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 194
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 194
Autofagia nei gliomi HG: analisi ed interpretazione di dati clinici e biologici 193
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 192
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 192
MR Volumetry of Rectal Cancer: DWI versus T2-weighted data sets. 190
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 190
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 189
Associazione Epirubicina e Vincristina (Ev) nel trattamento del carcinoma mammario metastatico. Risultati preliminari 184
Chirurgia conservativa e radioterapia a dosi "moderate" nel carcinoma mammario in fase iniziale. 183
Restaging patients with N2 non-small cell lung cancer after neoadjuvant therapy: TCMS accuracy using a multi-criteria approach 179
Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective? 177
Three-dimensional conformal radiotherapy, temozolomide chemotherapy and high-dose fractionated stereotactic boost in a protocol driven, post-operative treatment schedule for high-grade gliomas. 176
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 176
Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology) 175
Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes 174
The prognostic role of Beclin 1 protein expression in high-grade gliomas 173
In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, Mib1, and topoisomerase IIα protein expression. 171
Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines 171
Beta-catenin and Gli1 are important prognostic factors in glioblastoma: combination with p53, EGFR and Mib1 markers to predict long term survival (paper #1628) 168
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status 167
Basi scientifiche per la definizione di linee-guida in ambito clinico per i tumori della tiroide dell’epitelio follicolare. 167
Adjuvant radiotherapy after radical prostatectomy: multinstitutional experience 165
Benign lymphoepithelial lesion associated with squamous cell carcinoma of the skin: an immunohistochemical and molecular genetic study 165
Spindle cell lipoma of the orbit: a case report of an unusual orbital pathology 164
Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report [La volumetria con risonanza magnetica pesata in diffusione nella valutazione della risposta alla chemio-radioterapia nel tumore del retto: studio preliminare] 164
Impact of timing of radiotherapy after conservative breast surgery on local control and metastases in pTis-T1-T2 N0 patients.Tuscany and Umbria Radiotherapy Departments experience. 163
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO). 163
Surrenalectomia medica con aminoglutetimide nel carcinoma mammario in fase avanzata 157
Tumori tiroidei 156
Neoplasie di encefalo, occhio-orbita, ipofisi e midollo spinale 156
NEOPLASIE CEREBRALI, LINEE GUIDA AIOM. 152
Risultati terapeutici nel carcinoma mammario sottoposto a trattamento conservative basato sulla radioterapia. Lo standard di cura nel sud-est della Toscana negli anni 1996-2000 150
High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer 148
Unresectable retroperitoneal malignant fibrous histiocytoma: Prolonged complete remission following chemoradiotherapy 146
Neoplasie della sfera Otorinolaringoiatrica 145
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 145
Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism? 144
The role of Radiation Oncologist in the management of antineoplastic drugs in Italy 142
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 140
null 139
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: a role for autophagy 139
Primary neuroendocrine (Merkel cell) carcinoma of the eyelid in a young woman - Report of a Case 137
Cytoplasmatic expression of the Beclin 1 autophagy protein gene product in a sereis of malignant glioma patients undergoing radio- and chemotherapy: a preliminary report. 137
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 135
La radioterapia oncologica 132
Lymphatic vascularization in prostate adenocarcinoma: Correlation with tumor grade, androgen withdrawal and prognosis 132
null 130
Prophylactic whole brain irradiation after complete response to primary treatment in limited stage small cell lung cancer: the experience of four radiotherapy units in Tuscany. 127
null 126
Epidermal Growth Factor Receptor Expression May Correlate with Survival Through Clinical and Radiological Features of Aggressiveness in Glioblastoma Treated with Radiochemotherapy 126
Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques [La radioterapia dei gliomi maligni. I risultati delle modalità tradizionali di trattamento e le prospettive delle tecniche avanzate] 124
Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas 123
Autophagy in Human Brain Cancer 122
The Istituto Toscano Tumori (ITT) and the radiotherapy Centers. 121
Updating the role of radiotherapy in the management of epithelial ovarian cancer 121
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 120
Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects 118
Conservative surgery and radiotherapy for ductal carcinoma of the breast. A retrospective analysis of 141 patients 118
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in twelve italian radiation oncology centers 118
null 117
null 116
In Regard to Kubicek et al. 114
Polichemioterapia precauzionale con cmf classico nel carcinoma della mammella con linfonodi ascellari positivi 114
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 113
Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. 109
Totale 18.463
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.424 0 0 0 0 0 347 72 297 199 202 123 184
2021/20221.355 100 149 132 97 69 54 58 73 70 141 118 294
2022/20232.066 114 162 291 292 200 401 34 177 197 86 65 47
2023/20241.679 59 38 139 85 61 451 622 59 9 52 22 82
2024/20253.043 92 146 290 164 396 210 48 180 180 128 362 847
2025/20265.260 631 1.049 757 915 1.694 214 0 0 0 0 0 0
Totale 21.225